Intellectual Property and FDA Considerations for Biotechnology and Medical Device Projects

Effective product development in the medical device and biotechnology industries requires a company to understand both the intellectual property (IP) and Food and Drug Administration (FDA) implications of its work. By proposing a series of questions that participants can use to assess their projects, this seminar will help engineers, designers and project managers to better understand the medical device and biotechnology product development process. Companies integrating knowledge of FDA regulatory requirements and IP portfolio management into their product development processes are more likely to experience success.  

• Understanding the basics of patent and FDA regulatory application processes
• Identifying key intersection points between patent application and FDA regulatory processes
• Implementing practical workforce tools for successful product development